Diary - News
All news genOway announces capacity expansion at new facilities
Lyon, France, May 30th: genOway (Alternext-NYSE Euronext: ALGEN; ISIN: FR0004053510), the biotechnology company dedicated to the design and development of genetically modified models, is celebrating the purchase of brand new laboratory located in Lyon Biopole-Techsud with operation beginning in early 2018. This significant expansion of capacity showcases the fruit of genOway’s investment in growth that will greatly enhance its service and production capabilities.
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree